{
  "id": "04f399f7-f4f7-4a72-8d5d-a8d758819b06",
  "title": "KKR may sell $300-m stake in JB Chemicals",
  "link": "https://economictimes.indiatimes.com/markets/stocks/news/kkr-may-sell-300-m-stake-in-jb-chemicals/articleshow/119564173.cms",
  "description": "The floor price has been set at ₹1,625 per share, a 4.9% discount to Wednesday's closing price of ₹1,695 on NSE. The base offer comprises 10.6 million shares (6.8% stake) worth ₹1,717.4 crore, along with a greenshoe option of 5.3 million shares (3.4% stake) valued at ₹858.7 crore.",
  "author": "",
  "published": "Thu, 27 Mar 2025 05:32:03 +0530",
  "source": "https://economictimes.indiatimes.com/rssfeedsdefault.cms",
  "categories": null,
  "byline": "ET Bureau",
  "length": 1257,
  "excerpt": "The floor price has been set at ₹1,625 per share, a 4.9% discount to Wednesday's closing price of ₹1,695 on NSE. The base offer comprises 10.6 million shares (6.8% stake) worth ₹1,717.4 crore, along with a greenshoe option of 5.3 million shares (3.4% stake) valued at ₹858.7 crore.",
  "siteName": "Economic Times",
  "favicon": "",
  "text": "Mumbai: Global private equity firm KKR plans to sell up to ₹2,576 crore ($300 million) worth of shares in JB Chemicals \u0026 Pharmaceuticals through a block deal on Thursday, showed a term sheet issued by the participating banks. The sale represents a potential 10.2% stake in the company.The floor price has been set at ₹1,625 per share, a 4.9% discount to Wednesday's closing price of ₹1,695 on NSE. The base offer comprises 10.6 million shares (6.8% stake) worth ₹1,717.4 crore, along with a greenshoe option of 5.3 million shares (3.4% stake) valued at ₹858.7 crore. AgenciesAs of December-end, KKR, through its firm Tau Investment Holdings Pte, held a 53.66% stake in JB Chemicals. In 2020, KKR bought a 54% stake in JB Chemicals for ₹3,109 crore. The deal was executed at ₹745 per share. In September 2023, JB Chemicals split its stock by half to ₹1. Adjusted for the stock split, KKR made returns of 336% over the past five years.KKR has been considering selling its controlling stake in JB the past year. The stock has rallied 74% in the last two years, sharply outperforming a 39% rise in the Nifty index. IIFL Capital Services, Jefferies India, Kotak Securities, and Spark Institutional Equities are the book running lead managers for the transaction.",
  "image": "https://img.etimg.com/thumb/msid-119564226,width-1200,height-630,imgsize-11044,overlay-etmarkets/articleshow.jpg",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-brcount=\"10\"\u003e\u003cp\u003eMumbai: Global private equity firm KKR plans to sell up to ₹2,576 crore ($300 million) worth of shares in JB Chemicals \u0026amp; Pharmaceuticals through a block deal on Thursday, showed a term sheet issued by the participating banks. The sale represents a potential 10.2% stake in the company.\u003c/p\u003e\u003cp\u003eThe floor price has been set at ₹1,625 per share, a 4.9% discount to Wednesday\u0026#39;s closing price of ₹1,695 on NSE. The base offer comprises 10.6 million shares (6.8% stake) worth ₹1,717.4 crore, along with a greenshoe option of 5.3 million shares (3.4% stake) valued at ₹858.7 crore. \u003c/p\u003e\u003cdiv data-align=\"\" data-msid=\"119564288\" data-type=\"image\"\u003e\u003cfigure\u003e\u003cimg title=\"KKR may Sell $300-m Stake in JB Chemicals\" alt=\"KKR may Sell $300-m Stake in JB Chemicals\" src=\"https://img.etimg.com/photo/msid-119564288/kkr-may-sell-300-m-stake-in-jb-chemicals.jpg\" data-msid=\"119564288\" data-original=\"https://img.etimg.com/photo/msid-119564288/kkr-may-sell-300-m-stake-in-jb-chemicals.jpg\"/\u003e\u003cspan\u003eAgencies\u003c/span\u003e\u003c/figure\u003e\u003c/div\u003e\u003cp\u003eAs of December-end, KKR, through its firm \u003ca ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" href=\"https://economictimes.indiatimes.com/topic/tau-investment-holdings-pte\" target=\"_blank\"\u003eTau Investment Holdings Pte\u003c/a\u003e, held a 53.66% stake in JB Chemicals. \u003c/p\u003e\u003cp\u003eIn 2020, KKR bought a 54% stake in JB Chemicals for ₹3,109 crore. The deal was executed at ₹745 per share. In September 2023, JB Chemicals split its stock by half to ₹1. Adjusted for the stock split, KKR made returns of 336% over the past five years.\u003c/p\u003e\u003cp\u003eKKR has been considering selling its controlling stake in JB the past year. The stock has rallied 74% in the last two years, sharply outperforming a 39% rise in the Nifty index. \u003ca rel=\"dofollow\" href=\"https://economictimes.indiatimes.com/iifl-capital-services-ltd/stocks/companyid-22223.cms\" data-ga-onclick=\"Inarticle articleshow link click#Markets#href\" target=\"_blank\"\u003eIIFL Capital Services\u003c/a\u003e, Jefferies India, Kotak Securities, and Spark Institutional Equities are the book running lead managers for the transaction.\u003c/p\u003e\u003cbr/\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "2 min read",
  "publishedTime": "2025-03-27T05:32:00+05:30",
  "modifiedTime": null
}
